27420-1-AP

antibody from Proteintech Group

Targeting: ELK1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

27420-1-AP

Provider

Proteintech Group

Product name

ELK1 antibody

Antibody type

Polyclonal

Description

KD/KO validated ELK1 antibody (Cat. #27420-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

FAK/SRC-JNK axis promotes ferroptosis via upregulating ACSL4 expression.

Qin J, Ma S, Wang J, Huang S, Luan J, He J, Hou G, Sun N, Zhang W, Gao M
Cell death & disease 2026 Mar 20;17(1)

---

Exosomal microRNAs of tuberculous pleural effusion orchestrating TGF-β signaling mediate pleural fibrosis.

Jiang LJ, Zheng YY, Liang LM, Jia ZH, Du RH, Huang H, Dai X, Cheng PP, Zhao LQ, Li Q, Jiang YH, Cui XL, Ye SY, Hu SH, Zhang HD, Lian CY, Feng X, Song LJ, Yu F, He XL, Xiong L, Xiang F, Wang X, Liu AD, Wang M, Ye H, Ma WL
Respiratory research 2026 Feb 3;27(1)

---

Multi-kinase-mediated alterations in Tau phosphorylation, synaptic proteins, and choline metabolism in a human neuronal in vitro model exposed to the elastin-derived hexapeptide VGVAPG.

Skóra B, Piechowiak T, Szychowski KA
Neuropharmacology 2026 Feb 15;284:110781

---

Netrin-1 Promotes Pancreatic Tumorigenesis and Innervation through NEO1.

Kobayashi H, Ochiai Y, Arai J, Hata M, Wu F, Sunagawa M, Iida T, Baba T, Malagola E, Tanaka T, Jiang Z, White RA, Zhi X, Qian J, Waterbury QT, Tu R, Zheng B, Zeng Y, Zheng H, Zhang P, Li S, Zamechek LB, LaBella JS, Sugie T, Enomoto A, Eltzschig HK, Palermo CF, Chio IIC, Olive KP, Wang TC
Cancer research 2026 Apr 15;86(8):1883-1901

---

TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4.

He Z, Zheng D, Li F, Chen L, Wu C, Zeng Z, Yu C
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2025 Jan;78:101171

---

LHPP-mediated inorganic pyrophosphate hydrolysis-driven lysosomal acidification in astrocytes regulates adult neurogenesis.

Sha L, Li J, Shen H, Wang Q, Meng P, Zhang X, Deng Y, Zhu W, Xu Q
Cell reports 2023 Aug 29;42(8):112975

---

Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer.

Lang L, Chen F, Li Y, Shay C, Yang F, Dan H, Chen ZG, Saba NF, Teng Y
Cancer research communications 2023 Apr;3(4):659-671

---

Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation.

Cui D, Li J, Zhu Z, Berk M, Hardaway A, McManus J, Chung YM, Alyamani M, Valle S, Tiwari R, Han B, Goudarzi M, Willard B, Sharifi N
The Journal of clinical investigation 2023 Apr 3;133(7)

---

The SETD8/ELK1/bach1 complex regulates hyperglycaemia-mediated EndMT in diabetic nephropathy.

Li X, Lu L, Hou W, Wang F, Huang T, Meng Z, Zhu M
Journal of translational medicine 2022 Mar 29;20(1):147

---

GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.

Wei S, Yu Z, Shi R, An L, Zhang Q, Zhang Q, Zhang T, Zhang J, Wang H
BMC cancer 2022 Aug 12;22(1):881

---

tRNA-Derived Fragment tRF-Glu-TTC-027 Regulates the Progression of Gastric Carcinoma via MAPK Signaling Pathway.

Xu W, Zhou B, Wang J, Tang L, Hu Q, Wang J, Chen H, Zheng J, Yan F, Chen H
Frontiers in oncology 2021;11:733763

---

CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p.

Sun R, Li H, Li J, Shen S, Cui G, Dong G
Biochemical and biophysical research communications 2020 Dec 17;533(4):845-852

---

Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.

Ahmad A, Zhang W, Wu M, Tan S, Zhu T
Genes & genomics 2018 Mar;40(3):243-251